Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$84.3 - $94.31 $758 - $848
9 Added 0.3%
2,966 $273,000
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $507 - $668
7 Added 0.24%
2,957 $282,000
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $182,044 - $229,392
2,950 New
2,950 $224,000
Q2 2023

Aug 02, 2023

SELL
$81.41 - $94.33 $5,780 - $6,697
-71 Reduced 2.26%
3,071 $289,000
Q1 2023

Apr 21, 2023

BUY
$74.26 - $84.51 $4,232 - $4,817
57 Added 1.85%
3,142 $259,000
Q4 2022

Feb 09, 2023

BUY
$68.3 - $87.44 $1,844 - $2,360
27 Added 0.88%
3,085 $230,000
Q3 2022

Oct 24, 2022

SELL
$82.37 - $107.29 $3,459 - $4,506
-42 Reduced 1.35%
3,058 $253,000
Q2 2022

Jul 29, 2022

SELL
$86.5 - $128.27 $7,612 - $11,287
-88 Reduced 2.76%
3,100 $295,000
Q1 2022

May 17, 2022

BUY
$101.96 - $128.34 $4,078 - $5,133
40 Added 1.27%
3,188 $375,000
Q4 2021

Jan 19, 2022

SELL
$106.37 - $130.68 $41,058 - $50,442
-386 Reduced 10.92%
3,148 $408,000
Q3 2021

Nov 09, 2021

BUY
$102.91 - $122.75 $205 - $245
2 Added 0.06%
3,534 $400,000
Q2 2021

Aug 09, 2021

BUY
$83.84 - $104.76 $19,786 - $24,723
236 Added 7.16%
3,532 $366,000
Q1 2021

Apr 29, 2021

BUY
$78.68 - $90.67 $7,395 - $8,522
94 Added 2.94%
3,296 $276,000
Q4 2020

Jan 28, 2021

BUY
$71.69 - $91.23 $716 - $912
10 Added 0.31%
3,202 $292,000
Q3 2020

Nov 09, 2020

SELL
$67.19 - $87.44 $67 - $87
-1 Reduced 0.03%
3,192 $255,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $122,214 - $163,441
2,124 Added 198.69%
3,193 $221,000
Q1 2020

Apr 23, 2020

SELL
$52.41 - $81.0 $419 - $648
-8 Reduced 0.74%
1,069 $202,000
Q4 2019

Jan 28, 2020

BUY
$71.7 - $82.09 $215 - $246
3 Added 0.28%
1,077 $251,000
Q3 2019

Oct 23, 2019

BUY
$61.55 - $75.43 $66,104 - $81,011
1,074 New
1,074 $236,000
Q2 2019

Jul 12, 2019

SELL
$55.74 - $64.41 $60,031 - $69,369
-1,077 Closed
0 $0
Q1 2019

May 01, 2019

BUY
$47.89 - $64.05 $51,577 - $68,981
1,077 New
1,077 $206,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wealth Architects, LLC Portfolio

Follow Wealth Architects, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Architects, LLC with notifications on news.